Tuesday, April 20, 2021

Investorideas.com - US House Passes Bill To Normalize Adult-Use Cannabis Commerce

Investorideas.com - US House Passes Bill To Normalize Adult-Use Cannabis Commerce

Investorideas.com - Is the Trend Turning for This Psychedelic Stock?

Investorideas.com - Is the Trend Turning for This Psychedelic Stock?

Investor Ideas Potcasts #554 Cannabis News and Stocks on the Move: Happy 4/20! (CSE:XTRX) (TSX: CWEB) (OTCQX: CWBHF), (OTC: HIPH), (OTC:VSYM) (OTC: BSPK)

Delta, Kelowna, BC - April 20, 2021 (Investorideas.com Newswire) www.Investorideas.com, a global news source covering leading sectors including marijuana and hemp stocks and its potcast site, www.potcasts.ca release today's podcast edition of cannabis news and stocks to watch plus insight from thought leaders and experts.

Listen to the podcast:

https://www.investorideas.com/Audio/Podcasts/2021/042021-StocksToWatch.mp3

Investor Ideas Potcasts #554 Cannabis News and Stocks on the Move: Happy 4/20! (CSE:XTRX), (TSX: CWEB) (OTCQX: CWBHF), (OTC: HIPH), (OTC:VSYM) (OTC: BSPK)

SHARE PODCAST:      

Hear Investor ideas cannabis potcast on iTunes

Hear the investor ideas potcast on Spotify

Today's podcast overview/transcript:

Good afternoon and welcome to another episode of Investorideas.com "Potcast" featuring cannabis news, stocks to watch as well as insights from thought leaders and experts.

Today's podcast is sponsored by Phyto Extractions Inc. (CSE:XTRX), an agricultural-scale cannabis extraction, distillation and product manufacturer located in Langley, BC at its co-located Health Canada Licensed Standard Processing (extraction, no cultivation), Sales (extracts, topicals, and edibles) through Adastra Labs Inc. and Analytical Testing Laboratory through Chemia Analytics Inc. Adastra Labs also has a pending Health Canada R&D license amendment.

Happy 4/20, in today's podcast we look at a few private and public company announcements.

But first, the cannabis industry got an early 4/20 present yesterday as lawmakers in the U.S. House of Representatives approved the Secure and Fair Enforcement (SAFE) Banking Act (H.R. 1996) in a floor vote of 321-101. This legislation would prevent federal regulators from punishing financial institutions that provide services to state-legal cannabis businesses. Currently, most banks are unwilling to work with the cannabis industry because they fear federal prosecution.

The SAFE Banking Act previously cleared the House in 2019. The language of the bill was also included in two rounds of COVID-19 relief packages that were approved by the House. A version of this legislation has been introduced in the Senate (S. 910) and currently has 32 cosponsors.

Statement from Steve Hawkins, executive director at the Marijuana Policy Project:

"This vote marks a meaningful first step in establishing a more equitable cannabis industry and improves the likelihood that other cannabis legislation will advance at the federal level.

"Restricting cannabis businesses from accessing financial services creates an unnecessary burden for the industry and limits economic growth. If enacted into law, the SAFE Banking Act would strengthen efforts to increase the diversity of the cannabis industry by providing resources for those with limited access to capital and increasing the chances of success for state-level social equity initiatives. Further, it would protect the 321,000 employees directly affected by the cannabis industry's lack of access to financial services."

Steve Hawkins is both the Executive Director of the Marijuana Policy Project and the Interim President of the U.S. Cannabis Council.

Charlotte's Web Holdings, Inc. (TSX: CWEB) (OTCQX: CWBHF), a certified B Corporation and the market leader in hemp CBD extract products, today announced that three of its proprietary hemp cultivars were approved for registration on Health Canada's List of Approved Cultivars for outdoor cultivation in Canada. These are among the first hemp CBD cultivars on the LOAC that are early flowering and early maturing for outdoor cultivation and harvesting within the shorter Canadian growing season. The approved cultivars include the Company's original "CW1AS1" U.S. patented genetics, clearing the way for Charlotte's Web to cultivate its leading CBD wellness products in Canada in 2021. Currently, Charlotte's Web Products are not easily available in Canada because laws do not allow for bulk importing of USA grown hemp CBD or related products into Canada.

"Today, Charlotte's Web is the leading hemp wellness company in the U.S. with the most recognized and trusted hemp CBD extract," said Deanie Elsner, Charlotte's Web president and CEO. "We aspire to be the world's leading botanicals wellness company, entering countries with an asset light model where federal laws permit hemp extracts for health and wellness. Israel and Canada are included in the first steps of our international expansion."

In addition to the Company's CW1AS1 cultivar used for its leading Original Formula and other full-spectrum hemp extract products, Charlotte's Web is bringing two early maturing hemp varieties to Canada - named "Duchess" and "Ambassador" - developed for cultivation in shorter northern climate growing seasons.

Charlotte's Web's approved cultivars are three of 15 added to the 2021 LOAC. "The majority of approved cultivars on the LOAC to date have been for industrial hemp grown to produce food, fiber, and animal feed. Now our approved cultivars are paving the way for full-spectrum hemp CBD demand in Canada and most importantly, will provide access to Charlotte's Web products in Canada," explained Jared Stanley, co-founder and chief cultivation officer of Charlotte's Web.

Despite Canada being one of the first countries to federally legalize the sale of cannabis, the hemp CBD wellness category is underdeveloped in Canada, with limited offerings of quality full-spectrum hemp extract products. Most CBD products in Canada are produced from cannabis with THC levels well above 0.3% which have an intoxicating effect. Charlotte's Web hemp cultivars are cultivated below 0.3% THC, resulting in full-spectrum extracts with wellness benefits, but without the intoxication from THC.

Currently, Health Canada treats hemp CBD under the same regulatory regime as cannabis THC. The Canadian hemp industry is lobbying the Canadian federal government to change the regulations for hemp CBD to a natural health supplement that could be added to food, drinks, cosmetics and other wellness products. Hemp CBD products could then be sold in all types of retailers across Canada, which would help meet demand for the product. In September 2020 a report prepared by the Institute of Fiscal Studies and Democracy (IFSD) concluded that if Ottawa regulated CBD like regular health products it would open an annual market worth more than C$2 billion with immense potential for exporting CBD to other countries.

Harvest Brothers Corp, a Canadian start-up dedicated to the distribution of products for home cannabis cultivation, today announced its first distribution agreement with Robonica, the producer of Linfa, the world's leading cannabis grow box.

"We chose Linfa," said Paolo Levi, CEO of Harvest Brothers Corp, "after an exhaustive review revealed that Linfa produces higher quality cannabis at lower cost than any other grow box. Plus it is the easiest to use, so small it can fit almost anywhere, and looks great."

"We are happy to have reached a distribution agreement for North America with Harvest Brothers Corp," added Harald Cosenza, founder of Robonica. "Our products are already used by more than a thousand happy European growers and now we are able to offer them to the North American market. Linfa is even more useful in Canada, where the climate means it is not easy to have harvests available all year round."

Linfa is a smart, hydroponic cannabis grow box that makes it easy for anyone to grow cannabis at home:

  • Grow all year round and harvest every two months
  • Simple and intuitive: no green thumb required!
  • Automatic cultivation management
  • Grow up to 4 plants simultaneously
  • Wi-FI and Webcam to follow your cultivations remotely
  • Stylish Italian design
  • Small, can fit almost anywhere
  • Healthy: no pesticides

Linfa's high quality cannabis is produced thanks to a special app that allows you to monitor the growing process through your mobile phone. Linfa has an onboard computer and a webcam capable of photographing the status of the plants under cultivation and informing the user, through a mobile notification system, of how to achieve a successful harvest in a completely automatic way.

The product is compact in size (59x52x35 cm, or 31x15x11 inches) and can be installed in 15 minutes by anyone in any size apartment.

Its hexagonal shape, white color and attention to detail make Linfa a product not only easy to use but beautiful and pleasant to have in the home.

Now Canadian home cannabis growers will be able to appreciate the advantages of Linfa, until now available only in Europe.

In celebration of 4/20, the price this week is $899 CAD, discounted from the regular price of $1,099 CAD.

American Premium Water Corporation (OTC: HIPHannounced it has come to terms on the acquisition of licenses to distribute and retail hemp cannabinoids in the State of New York as part of the State's program to establish quality control standards on the industry. The Company expects to close the transaction by the end of the 1st half 2021. (Disclosure: The Company acquired these licenses from a New York entity that was owned by CEO, Ryan Fishoff. The proposed consideration for the licenses is nominal.)

According to a report released by Grandview Research, New York State's cannabis market is expected to be worth over $7 billion by 2025. The New York State hemp cannabinoid program oversees the licensing of processors, distributors, and retailers, setting quality control standards that all hemp products must meet including manufacturing, packaging and labeling and laboratory testing requirements.

Ryan Fishoff, CEO of American Premium Water, commented, "I am excited to announce that the Company is set to acquire licenses to distribute and retail Hemp Cannabinoids in the State of New York. This is significant for the Company, as it further positions us to be dominant players in the Northeast. I feel that New York will become our hub for selling activities in the region. It is also my home state and I know from firsthand experience how under developed the CBD and Hemp market is in the city (and region); there is a huge opportunity to establish significant market share out of the gate. Getting these licenses allow us (The Company) to establish a foothold and further distinguish us from other companies trying to enter the space. The retail license could be utilized to partner with a non-CBD company to collaborate on retail installations and pop-up shops. There are a lot of empty storefronts in Manhattan and I believe there is great opportunity to capitalize off of this.

"Today is 4/20 and we are excited to celebrate it with this news. This announcement is a kickoff for the commercial launch of our joint venture with CaliBear. The Company is excited to begin selling CaliBear CBD products in the coming weeks. The Company will be doing a number of promotional activities and announcements in the coming weeks to prepare for the online and retail launches. Our distribution partner, Just Logistics, is excited to work with us on the initial rollout to smoke shops throughout the Northeast corridor. The Company is also engaged in discussions with other distributors along the east and west coasts to carry CaliBear CBD products. It's an exciting time and the CaliBear team of influencers have hit the beach, participating in Olympic qualifying tournaments in Cancun. We have also begun reaching out to non-CBD companies to explore partnership opportunities to expand the reach of the CaliBear brand, and increase sales. Having the Hemp Cannabinoid licenses will be an asset in these conversations and I look forward to getting creative with these partnerships to further distinguish the brand not only in the Hemp/CBD space, but become a market leader in the performance lifestyle segment. I encourage shareholders and investors to keep their eyes open for announcements in the coming weeks as preparations for the CaliBear retail launch heat up like the temperatures outside!" concluded Mr. Fishoff.

View Systems, Inc.'s (OTC:VSYM), Sannabis S.A.S., a Colombian cannabis company, announced the development of a new product to supply the food and beverage industry with Cannabis flavorings. For several years Sannabis has been producing an essential oil with a mystical therapeutic essence that captivated users with the pure aroma and flavor of the botanical components of Cannabis. Sannabis redeveloped its essential oil into a Non-THC raw material that can be used by food and drink companies to flavor potentially hundreds of different products.

Recently PepsiCo announced their Rockstar Energy launched a line of hemp-infused drinks in Germany with an "intense Hemp flavor." PepsiCo says, "With outstanding category growth of 58% compared to the previous year, hemp products are the trend of the year for 2021 in the FMCG sector."

Sannabis aims to be a major supplier of not only the essence for this Food and Beverage Revolution, but also the hempseed oil needed to make these products. A large part of the smells and aromas associated with plants are due to the presence of terpenes and flavonoids. As opposed to Cannabinoids (CBD) with no smell or odor. Terpenes serve several functions in the plant to protect it from predators. Terpenes are compounds responsible for the aroma and flavors of cannabis, and support cannabinoids in producing desired effects. Flavonoids are similar to terpenes in that they contribute to a plant's aroma and flavor profile, but may offer their own unique therapeutic effects.

Sannabis believes the cocktail market to be a huge opportunity for them, they will approach makers of spirits and other beverages interested in enhancing their offerings with therapeutic effects. Companies interested in working with Sannabis should contact the company at info@viewsystems.com.

Recently Sannabis launched its "Holy Essence" product at top Salsa Dance Club in Cali-Colombia. Sannabis' Holy Essence is added to the drink glass before the drink is poured, then on the rim to give the user a pure therapeutic essence and aroma without altering the taste of their cocktail.

Last week, Sannabis announced approval by an Inspector from Colombia's Ministry of Agriculture of their Seed Bank facilities in anticipation of the Granting of a coveted Cannabis Seed Use License. Sannabis intends to work with the companies in the food and beverage industry interested in developing unique cannabis flavors and aromas by developing unique strains for their products.

"I believe cannabis flavorings will be a HUGE market because it takes 2 pounds of cannabis to produce 5 ml of Cannabis Essential Oil, I believe Colombia is the only country that can produce it at scale to provide this raw material at a cost affordable to the average consumer. It also can command a premium for bars and restaurants to charge their customers to add to their cocktails," stated John Campo, President of View Systems, Inc. and co-founder of Sannabis.

Bespoke Extracts, Inc. (OTC: BSPK), producer of high quality, hemp-derived CBD products, today announced that the Company has teamed with LEAF411™, a nonprofit, nurse-staffed information hotline to provide Bespoke customers with a free, qualified educational resource for information relating to the safe use of high quality, hemp-derived CBD products.

Founded in 2019, LEAF411 is a 501(c)(3) nonprofit operating a free cannabis-trained nurse hotline. Its mission is to provide education and directional support to the general public about the safe use of legal cannabis (marijuana and hemp). Its team of cannabis-trained nurses are passionate about helping consumers access balanced education about legal cannabis use while also improving public perception of the cannabis industry. The toll-free number to contact LEAF411 is 844-532-3411.

"As a provider of high quality CBD formulations for health and wellness-minded consumers, Bespoke is pleased to be partnering with LEAF411 to provide our customers with a trusted medical resource capable of addressing questions or concerns they may have relating to their use of CBD and other hemp-derived cannabinoids. Our Company underwent a vigorous due diligence process with LEAF411 to affirm that Bespoke meets their high standards for CBD manufacturers and which shares their commitment to quality, safety and service excellence. As such, we are very proud to be included among their vetted members who are making this invaluable information resource available to our respective customers," stated Danny Pollack, Chief Executive Officer of Bespoke Extracts.

Once again, today's podcast is sponsored by Phyto Extractions Inc. (CSE:XTRX), an agricultural-scale cannabis extraction, distillation and product manufacturer located in Langley, BC at its co-located Health Canada Licensed Standard Processing (extraction, no cultivation), Sales (extracts, topicals, and edibles) through Adastra Labs Inc. and Analytical Testing Laboratory through Chemia Analytics Inc. Adastra Labs also has a pending Health Canada R&D license amendment.

Investor ideas reminds all listeners to read our disclaimers and disclosures on the Investorideas.com website and that this podcast is not an endorsement to buy products or services or securities. Investors are reminded all investment involves risk and possible loss of investment.

Learn more about our cannabis podcasts at https://www.investorideas.com/Audio/Potcasts.asp

Or www.potcasts.ca

Investors can trade these stocks and other ideas on our site using our list of top stock trading apps including Robinhood , Acorn, Stash and others.

To hear more Investorideas.com podcasts visit: https://www.investorideas.com/Audio/.

The Investorideas.com podcasts are also available on iTunes (Apple Podcasts), Audible, Spotify, Tunein, Stitcher, Spreaker.com, iHeartRadio, Google Play Music and most audio platforms available.

Potcasts is now a certified word mark Trademark on the blockchain through Cognate, Inc. CM Certification-Registration Number: 10468217708

About Investorideas.com - News that Inspires Big Investing Ideas

Investorideas.com is a recognized news source publishing third party news, research and original financial content. Learn about investing in stocks and sector trends with our news alerts, articles, podcasts and videos, looking at cannabis, crypto, AI and IoT, mining, sports biotech, water, renewable energy and more. Investor Idea's original branded content includes the following podcasts and columns: Crypto CornerPlay by Play sports and stock news column, Investor Ideas Potcasts Cannabis News and Stocks on the Move podcast and column, Cleantech and Climate ChangeExploring Mining the AI Eye.

Disclaimer/Disclosure: Investorideas.com is a digital publisher of third party sourced news, articles and equity research as well as creates original content, including video, interviews and articles. Original content created by investorideas is protected by copyright laws other than syndication rights. Our site does not make recommendations for purchases or sale of stocks, services or products. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. All investing involves risk and possible losses. This site is currently compensated for news publication and distribution, social media and marketing, content creation and more. Disclosure is posted for each compensated news release, content published /created if required but otherwise the news was not compensated for and was published for the sole interest of our readers and followers.

Contact management and IR of each company directly regarding specific questions.

More disclaimer info: https://www.investorideas.com/About/Disclaimer.asp Learn more about publishing your news release and our other news services on the Investorideas.com newswire https://www.investorideas.com/News-Upload/ and tickertagstocknews.com

Global investors must adhere to regulations of each country. Please read Investorideas.com privacy policy: https://www.investorideas.com/About/Private_Policy.asp

Investor Ideas does not condone the use of cannabis except where permissible by law. Our site does not possess, distribute, or sell cannabis products.

Learn more about sponsoring this podcast or be a guest and our other branded content opportunities at Investorideas.com

Follow us on Cannabis Social Media

https://www.facebook.com/Investorideaspotcasts/

https://twitter.com/MJInvestorIdeas

https://www.instagram.com/investorideas_potcast/

Download our Mobile App for iPhone and Android

Contact Investorideas.com

800-665-0411


Get more Cannabis Stock Investor Ideas - news, articles, podcasts and stock directories

Buy a cannabis guest post on Investorideas.com

Breaking #Crypto/#Cannabis #Stock News - GCAC (CSE: $APP.C) ( FSE: 2FA) (OTCQB: $FUAPF) Launches Uniswap Marketing Token; @CitizenGreenWld

  

Breaking #Crypto/#Cannabis #Stock News - GCAC (CSE: $APP.C) ( FSE: 2FA) (OTCQB: $FUAPF) Launches Uniswap Marketing Token; @CitizenGreenWld

 

Adds #Ether #Cryptocurrency as Alternative Asset to Balance Sheet

 


Vancouver, British Columbia, Canada, April 20, 2021 – (Investorideas.com Newswire ) Global Cannabis Applications Corp. ("GCAC" or the "Company") (CSE: APP, FSE: 2FA, OTCQB: FUAPF), a leading medical cannabis chain-of-custody compliance and data platform, announced today that it has launched a Uniswap token [1] as part of a digital marketing campaign aimed at the one million decentralized finance user community ‘DeFi’ [2].

 

Read this news featuring GCAC in full at https://www.investorideas.com/news/2021/cryptocurrency/04201GCAC-Uniswap-Marketing-Token.asp

 

Company believes that the Uniswap community is an excellent target audience as this key demographic are consumers that have disposable income, are under 34 years old and increasingly drawn to the use of cannabis products [3]. This multi-year marketing campaign aims to raise awareness of its Citizen Green products and its Efixii ‘QR codes’ by launching a Uniswap token on the Ethereum blockchain with the Company’s name, logo and website visible to all of the Uniswap community.

 

Company is publicly traded with audited financials and makes accurate revenue disclosures. GCAC’s Uniswap-inclusion marketing initiative is to commit to a marketing-spend of 1% of its quarterly sales revenue buying GCAC tokens on Uniswap every 3 months. Each Uniswap token-buy should lead to greater awareness of the Company’s products and drive potential new cannabis consumers to look for Efixii ‘QR codes’ on the products that they are purchasing on-line.

 

“First and foremost, We - Are - Blockchain. So, I’m delighted to expand our marketing reach to fellow blockchain proponents. Cannabis consumers come in many forms and I am really excited to be marketing directly to the Uniswap DeFi community and raising awareness of cannabis efficacy and quality amongst this rather liquid demographic,” stated Brad Moore, CEO.

 

Mega-cap companies like Tesla (TSLA) are diversifying their balance sheets by adding the Bitcoin cryptocurrency [4]. GCAC is now adding an Ether cryptocurrency based “alternative asset” to its balance sheet by buying GCAC marketing tokens on Uniswap with 1% of its revenues. GCAC represents the next generation of companies embracing alternative assets and continues to innovate and seek ways to expand awareness of the benefits of cannabis efficacy and product transparency.

 

The Uniswap GCAC marketing token is built and operated by Abbey Technology “Abbey” and this latest marketing token has a unique set of features including:

 

  . Company commitment to purchase GCAC tokens on Uniswap with 1% of its quarterly revenues

  . Preventing the smart contract from creating any new GCAC marketing tokens

  . Giving advance-notice disclosure of the ‘intent to redeem’ any Abbey Uniswap liquidity-pool

  . Giving advance-notice disclosure of the ‘intent to sell’ any Company “alternative asset” tokens

 

[1] https://info.uniswap.org/pair/0xf22645743415d8c06d78c8a4f0ea214041b4544f    

[2] https://medium.com/metamask/metamask-exceeds-1-million-monthly-active-users-9da72a1e915d

[3] https://www.warc.com/newsandopinion/news/40_of_us_consumers_would_try_out_cbd_products/41878

[4] https://apnews.com/article/tesla-buys-billion-bitcoin-061817c6795e75d1c3c9e9d6cfc4a911

 

About Global Cannabis Applications Corp. “GCAC”

GCAC is a global leader in designing, developing, SaaS licensing and acquiring innovative data technologies for the medical cannabis industry. The Citizen Green and Efixii platforms are the world's first end-to-end - from patient to regulator - medical cannabis data solutions. They use six core technologies: mobile applications, artificial intelligence, RegTech, smart databases, Ethereum blockchain and GCAC smart rewards. These technologies transparently disclose cannabis chain-of-custody events, thereby enabling patients to provide crowd-sourced medical cannabis efficacy data. Driven by digital and cannabis industry experts, GCAC is focused on generating revenue from SaaS licensing its technology and acquiring high quality cannabis datasets that improve patient outcomes and to become the world’s largest cannabis efficacy data provider.

For more Company information, please visit www.cannappscorp.com, or review its profiles on www.sedar.com and on the Canadian Securities Exchange's website www.thecse.com.

 

About Abbey Technology GmbH, “Abbey”

Abbey, a Swiss company, specializes in developing, licensing and operating innovative blockchain technologies. The “Public-Company to Uniswap-Token” marketing platform was invented by Abbey alongside its Ethereum layer-2 high-throughput blockchain software-as-a-service. For information on Uniswap-token marketing campaigns for public companies visit https://abbey.ch.

 

Press Contact

 Phone: +1 (800) 409-5679

 Email: info@cannappscorp.com

 

Forward-Looking Information 

This news release may include forward-looking information within the meaning of Canadian securities legislation, concerning the business of GCAC. Forward-looking information is based on certain key expectations and assumptions made by the management of GCAC. Although management of the Company believes that the expectations and assumptions on which such forward-looking information is based are reasonable, undue reliance should not be placed on the forward-looking information because GCAC can give no assurance that they will prove to be correct. Forward-looking statements contained in this news release are made as of the date of this news release. GCAC disclaims any intent or obligation to update publicly any forward-looking information, whether as a result of new information, future events or results or otherwise, other than as required by applicable securities laws.

 

The Canadian Securities Exchange has not reviewed and does not accept responsibility for the adequacy and accuracy of this information.

 

Paid News -Disclaimer/Disclosure: Investorideas.com is a digital publisher of third party sourced news, articles and equity research as well as creates original content, including video, interviews and articles. Original content created by investorideas is protected by copyright laws other than syndication rights. Our site does not make recommendations for purchases or sale of stocks, services or products. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. All investment involves risk and possible loss of investment. This site is currently compensated for news publication and distribution, social media and marketing, content creation and more. Contact each company directly regarding content and press release questions. Disclosure is posted for each compensated news release, content published /created if required but otherwise the news was not compensated for and was published for the sole interest of our readers and followers. Disclosure : this news release featuring Global Cannabis Applications Corp. is a paid for service  on Investorideas.com  More disclaimer info: https://www.investorideas.com/About/Disclaimer.asp Learn more about publishing your news release and our other news services on the Investorideas.com newswire https://www.investorideas.com/News-Upload/ and tickertagstocknews.com Please read Investorideas.com privacy policy: https://www.investorideas.com/About/Private_Policy.asp

 

About Investorideas.com

https://www.investorideas.com/About/

 

Sign up for free stock news alerts at Investorideas.com

https://www.investorideas.com/Resources/Newsletter.asp

 



Get more Bitcoin, Blockchain, Digital Currency stock investor ideas - news, articles, podcasts and stock directories

 

Monday, April 19, 2021

Investorideas.com - Merck Selects Rapidly Growing Psychedelic Medicine Company as Key Research Site

Investorideas.com - Merck Selects Rapidly Growing Psychedelic Medicine Company as Key Research Site

#Investing in #Functional and #Psychedelic #Mushrooms- #Stocks to watch- (OTC: $LRSV) (OTC: $MMEDF) (OTC: $TRMNF), (TSXV: $PSYB.V) (OTC: $TRUFF) @res_pet @mindmedco @NewWaveHolding @PSYBioLife @redlightholland

 #Investing in #Functional and #Psychedelic #Mushrooms- #Stocks to watch- (OTC: $LRSV) (OTC: $MMEDF) (OTC: $TRMNF), (TSXV: $PSYB.V) (OTC: $TRUFF) @res_pet @mindmedco @NewWaveHolding @PSYBioLife @redlightholland

 

Point Roberts WA, Delta, BC – April 19, 2021 - Investorideas.com, a leading investor news resource covering functional mushrooms and plant-based food alternatives releases a special report on the growing dominance of both functional and psychedelic mushrooms in the current health and wellness sector, featuring Link Reservations Inc. (OTC: LRSV).  Current medicinal trends and new research point to the phenomenal promise of fungi for the future of food, medicine and technology.

 

Read this news, featuring LRSV in full at https://www.investorideas.com/news/2021/lohas/04191LRSV-Psychedelic-Mushrooms.asp

 

Looking at just one single mushroom, Reishi, is used in many modern health and wellness products, according to Allied Market Research, “The global reishi mushroom market was valued at $3,096.9 million in 2019, and is projected to reach $5,059.4 million by 2027, registering a CAGR of 8.1% from 2021 to 2027. In 2019, the powder reishi mushroom segment accounted for the highest share in the reishi mushroom market size.”

 

Link Reservations Inc. (OTC: LRSV), a provider of wellness and cannabidiol (CBD) products for both humans and pets just recently announced the launch and availability to purchase  DailyLife CBD Immune, its immune boosting functional mushroom product. Featuring a combination of CBD and a spectrum of functional mushrooms (including Lion’s Mane), the tincture will be available for sale on the DailyLife CBD website.

 

“It is my pleasure to announce that we have now launched our first functional mushroom product. We have been researching the power of medicinal mushrooms for some time and it is great to be able to bring to market a product that combines the power of mushrooms with the anti-inflammatory benefits of CBD. The overall goal is to offer natural products that can strongly benefit our health and, with regards to DailyLife CBD Immune, to boost and maintain a healthy immune system,” commented Rene Lauritsen, CEO at Link Reservations Inc. “Health and wellbeing have been absolutely front of mind for everyone in the past 12 months, so creating a product that can naturally benefit people is a great achievement,” he added.

 

DailyLife CBD Immune features an organic blend of 13 different medicinal mushrooms, including Lions Mane, Turkey Tail, Chaga, Red Reishi, Cordyceps amongst others. By focusing on a variety of mushrooms, the product is able to encompass multiple immune boosting traits and benefits. In addition, DailyLife CBD Immune also includes 250mg of hemp oil CBD extract and 100mg of vitamin C which will add to the immune boosting benefits.

 

“We are excited with the first launch of the functional mushroom range and we look forward to see the reception while we work on the other projects in the pipeline. We look forward to sharing more developments as they arise through press releases,” ended Lauritsen.

 

Link Reservations isn’t alone in pivoting off CBD wellness products into the functional mushroom category as NEW WAVE HOLDINGS CORP. (CSE: SPOR) (OTC: TRMNF), an investment issuer that provides capital and support services recently announced the launch of its first mushroom products in a new functional mushroom collection, which will live under the Way of Will brand.

 

Way of Will, a natural wellness brand under New Wave and known for its aromatherapy-based products, revealed earlier this year that it will be introducing a new line of functional mushroom products in the upcoming months. Further to the announcement, the company is releasing the Functional Mushroom Powder and the Functional Mushroom Capsules from the collection to the U.S. market. Paving the way to a larger collection of specialty mushroom products, the mushroom powder and capsules will be the first step in Way of Will's journey into the psychedelics space.

 

The product launch, featuring a house-blend of five functional mushrooms and fungi available in both capsule and powder format, aim to naturally boost immunity. They are loaded with vitamins, nutrients, and antioxidants that support a healthy immune system. The capsules are designed with ease of consumption and convenience in mind, while the powder allows for versatile use by mixing and incorporating it into foods and beverages.

 

"Mushrooms are gaining popularity rapidly right now, but they're not a new phenomenon in food and medicine. They have been used in certain regions of the world for centuries for a plethora of health and wellness purposes," said Willie Tsang, founder and CEO of Way of Will.

 

Goldman Small Cap Research, a stock market research firm specializing in the small cap and microcap sectors, recently announced that it has published a new research report on Link Reservations, Inc. (OTC PINK:LRSV).. This report carries a price target of 10 .

 

Looking at the psychedelic mushroom space, which has been mostly dominated by news on psilocybin, we are now just beginning to see growing interest in compounds other than psilocin in psychoactive mushroom strains. PsyBio Therapeutics Corp. (TSXV: PSYB), a biotechnology company developing novel formulations of psychoactive medications produced by genetically modified bacteria for the treatment of mental health and other disorders and a leader in the field of psychedelic research and drug development, has initiated process development of its proprietary biosynthetic formulation of norbaeocystin in collaboration with the Advanced Biofuels and Bioproducts Process Development Unit, a scale-up facility managed by Lawrence Berkeley National Laboratory, a US Department of Energy national laboratory. Norbaeocystin is an analogue of psilocybin and is not a controlled substance. The Company has commenced Phase I of this process, including analytical chemistry technical transfer to establish detection methods for fermentation products and key feedstocks and metabolites.

 

As both functional and psychoactive mushrooms continue to grow in popularity, much as we have seen in the cannabis industry, infrastructure and supply chains are the next hurdle the mushroom industry must look to address. Red Light Holland Corp. (CSE: TRIP) (OTC: TRUFF), an Ontario-based corporation engaged in the production, growth and sale of a premium brand of magic truffles to the legal, recreational market within the Netherlands, recently announced that its wholly-owned subsidiary, RLH Netherlands B.V., has completed the acquisition of SR Wholesale B.V., one of the Netherlands' premiere distributors for quality psychedelic truffles. In 2020, SR Wholesale generated over $2.44 Million in revenues[1], and over $822,0001 in gross profit, with approximately $400,0001 of cash and working capital currently on hand. SR Wholesale also distributes popular CBD products, cannabis seeds, smart shop items, and headshop products, among others. SR Wholesale has established a distribution network of over 400 companies that sell their products across Europe, including working with sub-distributors which provide products to over 1,000 shops in countries like the Netherlands, Germany, Spain, Czech, Greece, UK, France, and Portugal.

 

Founded in 2017, SR Wholesale has grown to become one of the most recognized and trusted distribution companies in the Netherlands. In connection with the Acquisition, Red Light Holland announced that Mr. Shai Ramsahai, Founder of SR Wholesale, has joined the Red Light Holland team on closing as Vice-President to oversee the integration of SR Wholesale into the Red Light Holland ecosystem, and grow the distribution business for Red Light Holland globally. The acquisition will create immediate synergies and enhance Red Light Holland's growth and expansion strategy.

 

"The acquisition of SR Wholesale marks the latest step in the Company's growth and expansion strategy, as we continue to move forward with a positive business outlook focused on achieving revenue growth, profitability and value creation for our shareholders. We expect this transaction to serve as a launchpad for Red Light Holland to broaden operations, create new homes for our iMicrodose packs and build brand exposure into multiple European markets. Others companies in the sector can keep telling people or assuming how people should consume psilocybin years from now, while we will continue offering people what they want right now, while concentrating on immediate revenue, profit and growth" said Todd Shapiro, Chief Executive Officer and Director of the Company. "We are quite thrilled, after months of tough negotiations and careful due diligence, to move forward as the largest legal psychedelic distribution publicly traded company in the world.[2] As well, we are truly so pleased to work closely with Mr. Shai Ramsahai, who is one of the brightest, most determined and likeable entrepreneurs I've ever come across. And he is an absolute legend in the Netherlands!"

 

Other companies in the psychedelic mushroom sector include MindMed (OTC: MMEDF), a clinical-stage psychedelic medicine biotech company that discovers, develops and deploys psychedelic inspired medicines and therapies to address addiction and mental illness. The company is assembling a  drug development pipeline of innovative treatments based on psychedelic substances including Psilocybin, LSD, MDMA, DMT and an Ibogaine derivative, 18-MC. The Company is expanding its reach in psychedelic  research and recently announced,” MindMed Announces the Publication of New Data on Personalized MDMA Dosing.”

 

According to Fortune Business Insights, “The global mushroom market was valued at 12.74 million tons (MT) in 2018 and is projected to reach 20.84 million tons (MT) by 2026, exhibiting a CAGR of 6.41% in the forecast period.”

 

As new research and developments provide mounting evidence supporting the use of functional and psychedelic mushrooms as sustainable, healthy medical and food alternatives, it seems the fantastic world of fungi will be the topic of much discussion for years to come.  

 

About Investorideas.com - Investorideas.com is a recognized news source publishing third party news, research and original financial content. Learn about investing in stocks and sector trends with our news alerts, articles, podcasts and videos, looking at cannabis, crypto, AI and IoT, mining, sports biotech, water, renewable energy and more. Investor Idea’s original branded content includes the following podcasts and columns : Crypto Corner , Play by Play sports and stock news column, Investor Ideas Potcasts Cannabis News and Stocks on the Move podcast and column,  Cleantech and Climate Change , Exploring Mining  the AI Eye

 

Disclaimer/Disclosure :Our site does not make recommendations for purchases or sale of stocks, services or products. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. All investing involves risk and possible losses. This site is currently compensated for news publication and distribution, social media and marketing, content creation and more. Contact management and IR of each company directly regarding specific questions. Disclosure: this news article featuring LRSV is a paid for news release on Investorideas.com – third party (two thousand) More disclaimer info: https://www.investorideas.com/About/Disclaimer.asp Learn more about publishing your news release and our other news services on the Investorideas.com newswire https://www.investorideas.com/News-Upload/ and tickertagstocknews.com Global investors must adhere to regulations of each country. Please read Investorideas.com privacy policy: https://www.investorideas.com/About/Private_Policy.asp

 

Contact Investorideas.com

800-665-0411

 

Health, Wellness and Sustainability Stocks Research and News at Investorideas.com - investing ideas for a better world

Like Health, Wellness and Sustainability Stocks? View our LOHAS Stocks Directory

 

Get more Cannabis Stock Investor Ideas - news, articles, podcasts and stock directories